Skip to main content
Sanjeev Vasudevan, MD, Pediatric (General) Surgery, Houston, TX

SanjeevA.VasudevanMD(He/Him)

Pediatric (General) Surgery Houston, TX

Associate Professor, Pediatric Surgery, Baylor College of Medicine

Dr. Vasudevan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vasudevan's full profile

Already have an account?

  • Office

    6701 Fannin St
    Suite 1210
    Houston, TX 77030
    Phone+1 832-822-3135
    Fax+1 832-825-3141

Summary

  • I am a general pediatric surgeon specializing in surgical oncology. My primary focus is in children with complex pancreatic and hepatobiliary tumors such as Hepatoblastoma, HCC, UESL, benign liver tumors, solid pseudopapillary neoplasms of the pancreas and pancreaticoblastoma. I also have specialized expertise in neuroblastoma, endocrine tumors (pheochromocytoma, PNET), and soft tissue sarcoma.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Surgery, 2009 - 2011
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Surgery, 2001 - 2009
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2001

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2011 - 2025
  • OK State Medical License
    OK State Medical License 2014 - 2015
  • American Board of Surgery Surgery
  • American Board of Surgery Pediatric Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Fluorescent Dye Helps Guide Pediatric Liver Tumor Resection
    Fluorescent Dye Helps Guide Pediatric Liver Tumor ResectionMay 20th, 2021
  • Novel Combination Therapy Offers Promising Results for Treatment-Refractory Hepatoblastoma
    Novel Combination Therapy Offers Promising Results for Treatment-Refractory HepatoblastomaFebruary 22nd, 2024
  • Promising Results from Novel Combo Therapy for Stubborn Hepatoblastoma
    Promising Results from Novel Combo Therapy for Stubborn HepatoblastomaMarch 2nd, 2024

Grant Support

  • Mkp-8: Novel Phosphatase Overexpressed In NeuroblastomaNational Cancer Institute2005

Professional Memberships